Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

SCAI chimes in on concerns about paclitaxel devices
Cachexia common after stroke, linked to lower functional capacity
Measures of subclinical atherosclerosis differ by sex in heavy smokers
3D-printed sugary stent boosts speed of suturing arteries
Waiting for guideline-based ‘triggers’ before addressing severe AR may harm survival
Reperfusion suffers with in-hospital delays before stroke thrombectomy
PFO closure guards against recurrent stroke more than a decade later
Aspirin’s benefit in primary CVD prevention countered by bleeding risks
Troponin elevations in ‘normal range’ predict near-term cardiac events
FDA seeks to modernize 510(k) clearance pathway for medical devices